. Age-related increase in number of inclusions in brains of male C57BL/6 mice. LBP-like immunoreactive clusters were quantified in 25-pim coronal sections through the dorsal hippocampus. For each animal, the number of clusters per unilateral hippocampus was determined in several sections and subsequently averaged. Numbers of mice were 6, 5, 4, 9, 9, and 17 at ages 0 to 2, 6, 9 to 10, 12 to 13, 18 In preparation for electron microscopy, mice were perfused as described (5) or with 4% paraformaldehyde, 0.1% glutaraldehyde, and 15% saturated picric acid. Some sections were stained with antibodies to LBP or somatostatin, after which immunoreactive dusters were excised for electron microscopy. In other sections, blocks of tissue were removed without prior immunostaining. The samples were dehydrated, embedded in Epon, trimmed, and sectioned. Thick sections (adjacent to thin sections) were deplasticized in 4% sodium ethoxide and immunostained for LBP to localize dusters of granules, which were then studied in adjacent thin sections with a Hitachi H-600 electron microscope. 8. For strain comparisons, mice (7 to 9 months of age, retired breeders) were supplied by Jackson Laboratory (Bar Harbor, ME) and Charles River Laboratories (Wilmington, MA). To study the age-related appearance of the lesions, C57BL/6J mice were obtained from Jackson Laboratory at weaning and aged at the Gerontology Research Center, National Institute on Aging, National Institutes of Health. Young and old BALB/cByJ mice were obtained directly from Jackson Laboratory. 11 October 1991; revised 10 January 1992; accepted 28 January 1992
We reported (1) the presence of amyloidlike deposits in the hippocampus of transgenic mice that harbor a gene encoding the 42-amino acid amyloid fragment of the amyloid precursor protein. At the time of publication, transgene-positive mice showed the phenotype, while transgene-negative control mice did not. It was brought to our attention by D. L. Price that similar deposits had recently been identified in nontransgenic C57BL/6 mice. Because of the possibility of an endogenous genetic contribution to the described phenotype, we extended our analysis to additional, and older, transgene-negative littermates. We found that a number of them also had amyloid-like structures in the hippocampus. It thus appears that the two lines of transgenic mice described in our paper represent sub-strains prone to formation of these structures. Mice from other lines of transgenics with the same genetic background (B6D2F1 x ICR) appear to have these deposits much less frequently.
This new information raises questions about the extent to which the transgene contributed to the amyloid-like phenotype in these mice. Work is under way to show whether a transgene-dependent phenotype can be induced in other mouse strains that are not predisposed to this phenomenon. Until then, data in (1) cannot be used to support the conclusion that a 13/A4 transgene causes formation of amyloid-like deposits in mouse brain.
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